Investors to be highly selective on health digital startups in 2024

This is due to their concerns about profitability.

Digital health investment will be under scrutiny as investors start to become selective with digital health startups next year due to their concerns about profitable business models, insights from Economist Intelligence showed.

“The COVID-19 pandemic brought a boom in health-tech investment. However, with promising ventures such as Health IQ (US), Babylon Health (UK) and Pear Therapeutics (US) filing for bankruptcy in 2023, venture capital funding has been drying up,” read the report, citing an example of cautious investors.

Meanwhile, digital healthcare will develop along with regulatory frameworks, which will push markets to frame better laws for health data to protect patients’ sensitive information. 

“For example, Germany aims to have a fully accessible personal health record for everyone in the country by the end of next year,” read the report.

With AI used for healthcare tasks ranging from drug discovery and clinical trials to health consultations, its adoption is seen to increase in 2024.